Cipla

Cipla is a global pharmaceutical company dedicated to developing and manufacturing high-quality, affordable medicines. Its extensive portfolio comprises over 1,500 products across diverse therapeutic categories, delivered in more than 50 dosage forms. The company ensures broad accessibility of essential pharmaceutical solutions in various international markets.

Founded in 1935 by Dr. K.A. Hamied, Cipla emerged from the foundational principle of "Caring For Life." This core insight drove its mission to ensure access to vital medications, exemplified by its pioneering efforts in providing affordable HIV/AIDS treatments, significantly impacting global health equity.

Cipla serves healthcare professionals and patients across numerous geographies. The company’s vision remains rooted in its founding purpose: to continuously expand access to affordable healthcare solutions globally. It aims to address critical medical needs, solidifying its role as a key contributor to public health worldwide.